Effect of Pilates Training Versus High Intensity Interval Training on Cardiorespiratory Fitness in Asthmatic Patients
22 luglio 2026 aggiornato da: Ghidaa Elmahdi Eldomiaty, Horus University
To compare the effect of Pilates Training Versus High Intensity Interval Training on Cardiorespiratory Fitness in Asthmatic Patients.
Panoramica dello studio
Stato
Non ancora reclutamento
Condizioni
Descrizione dettagliata
Asthma is a widespread chronic inflammatory disease affecting over 300 million people globally, leading to approximately 461,000 deaths annually.
Exercise, particularly Pilates and high-intensity interval training, is critical for improving cardiorespiratory fitness and can enhance the quality of life for asthma patients, who often face reduced physical fitness and comorbidities like depression.
Pilates improves respiratory control and strengthens respiratory muscles, while high-intensity interval training enhances aerobic and anaerobic capacities, reduces inflammation, and improves maximal oxygen uptake (VO₂ max).
This study aims to establish guidelines comparing the effects of Pilates and high-intensity interval training on cardiorespiratory fitness in asthmatic patients.
Tipo di studio
Interventistico
Iscrizione (Stimato)
51
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Ghidaa Elmahdi Eldomiaty, Assistant lecturer
- Numero di telefono: +20 10 22143737
- Email: gelmahdi@horus.edu.eg
Luoghi di studio
-
-
-
Damietta, Egitto
- out-patient clinic, faculty of physical therapy, Horus university
-
Contatto:
- Ghidaa Elmahdi Eldomiaty, Assistant lecturer
- Numero di telefono: +20 10 22143737
- Email: gelmahdi@horus.edu.eg
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
No
Descrizione
Inclusion Criteria:
- 51 patients diagnosed with a clinical diagnosis of asthma and a history of respiratory illness, aged between 30 and 40 years.
- Medically stable and capable of performing physical exercise.
- All participants provided written informed consent before enrollment.
- body mass index 25.0 - 29.9 (overweight)
- Patients with partially controlled asthma according to the Asthma Control Questionnaire (ACQ) from 0 to 1.5.
Exclusion Criteria:
- Participants with musculoskeletal limitations, cardiovascular instability, or any contraindications to exercise were excluded.
- Uncontrolled hypertension.
- Cognitive impaired patients.
- Severe Anemic patients.
- Pregnancy.
- Recent cardiothoracic surgery.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Pilates exercises
Patients will receive Pilates exercises administered to Group A include five movements: The Hundred, Single Leg Stretch, Side Kick, Toe Taps, and Leg Pull Front all performed with structured breathing patterns to emphasize respiratory control and core stabilization.
|
17 Patients will perform Pilates exercises 40-60 mins, three times per week, over 8weeks. Pilates exercises include five movements: The Hundred, Single Leg Stretch, Side Kick, Toe Taps, and Leg Pull Front, all performed with structured breathing Patterns To Emphasize Respiratory Control And Core Stabilization
Breathing in slowly and deeply through the nose using the diaphragm with a minimum movement of the chest in a supine position with one hand placed on the chest and the other on the belly.
During breathing, practitioners should be careful that chest remains as still as possible and stomach moves against the hand focusing on contracting the diaphragm.
Generally, diaphragmatic breathing practitioners inhale and exhale for approximately six seconds, respectively
|
|
Sperimentale: low-volume high-intensity interval training
Patients will receive low-volume high-intensity interval training.
Participants will perform 3-minute High Intensity Interval Training intervals on a treadmill at 85- 90% of heart rate reserve, each followed by 2 minutes of moderate-intensity active recovery at 60% -70% of eart rate reserve.
The total time spent in the exercise session is 25-30 minutes.
|
Breathing in slowly and deeply through the nose using the diaphragm with a minimum movement of the chest in a supine position with one hand placed on the chest and the other on the belly.
During breathing, practitioners should be careful that chest remains as still as possible and stomach moves against the hand focusing on contracting the diaphragm.
Generally, diaphragmatic breathing practitioners inhale and exhale for approximately six seconds, respectively
17 patients will engage in low-volume high-intensity interval training complemented by diaphragmatic breathing exercises.
Each session begins with a 5-10 minute warm-up on a treadmill at 40% of heart rate reserve.
The targeted heart rate during high-intensity interval training is set at 85-90% of heart rate reserve plus resting heart rate.
Participants will complete 3-minute high-intensity interval training intervals at the specified intensity, alternating with 2 minutes of moderate-intensity recovery at 60-70% heart rate reserve.
Total exercise duration is 25-30 minutes, concluding with a 5-minute cool-down at 30% heart rate reserve.
|
|
Comparatore attivo: Diaphragmatic breathing exercises
Diaphragmatic breathing exercises involve inhaling slowly through the nose while keeping the chest still and allowing the diaphragm to move the stomach.
This is performed in a supine position, with one hand on the chest and the other on the belly, ensuring minimal chest movement.
Practitioners typically inhale and exhale over six seconds each.
|
Breathing in slowly and deeply through the nose using the diaphragm with a minimum movement of the chest in a supine position with one hand placed on the chest and the other on the belly.
During breathing, practitioners should be careful that chest remains as still as possible and stomach moves against the hand focusing on contracting the diaphragm.
Generally, diaphragmatic breathing practitioners inhale and exhale for approximately six seconds, respectively
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
assessment of maximum oxygen consumption
Lasso di tempo: At baseline and after 8 weeks
|
Cardiopulmonary exercise testing is essential for evaluating patient symptoms, disease severity, prognosis, and therapy responses.
It assesses the interaction of cardiovascular and pulmonary systems with other bodily systems.
maximum oxygen consumption is calculated using the Bruce protocol via the Ergo Spiro Device.
This protocol involves a multi-stage treadmill test, starting at a 10% grade and increasing speed and grade every three minutes until exhaustion.
Subjects must refrain from eating, smoking, and consuming caffeine before testing, and avoid intense exercise leading up to the test.
|
At baseline and after 8 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
assessment of Quality of Life
Lasso di tempo: At baseline and after 8 weeks
|
The Mini-Asthma Quality of Life Questionnaire is a shortened, 15-item version of the original questionnaire, designed to accurately assess the quality of life in asthmatic patients without consuming much time.
It evaluates four domains: symptoms, activity limitation, emotional function, and environmental stimuli, based on the respondents' experiences over the past two weeks.
it employs a 7-point Likert scale, where 7 indicates no impairment and 1 signifies significant impairment
|
At baseline and after 8 weeks
|
|
assessment of dyspnea
Lasso di tempo: At baseline and after 8 weeks
|
The Modified Borg Dyspnea Scale is a validated, numerical rating scale used to quantify the subjective perception of breathlessness during physical activity or exercise.
The scale ranges from 0 to 10, where 0 indicates no breathlessness and 10 represents maximal or extremely severe breathlessness.
Participants are instructed to rate their perceived level of dyspnea immediately after or during exercise, providing a simple, reliable, and clinically applicable measure of symptom intensity for monitoring exercise tolerance and evaluating treatment outcomes.
|
At baseline and after 8 weeks
|
|
assessment of asthma symptoms
Lasso di tempo: At baseline and after 8 weeks
|
Asthma Control Questionnaire (ACQ-6) is a six-item questionnaire designed to measure asthma symptoms.
The questionnaire is scored by the mean of all items (0-6), with higher scores indicating poorer control.
|
At baseline and after 8 weeks
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
25 luglio 2026
Completamento primario (Stimato)
1 novembre 2026
Completamento dello studio (Stimato)
30 novembre 2026
Date di iscrizione allo studio
Primo inviato
22 luglio 2026
Primo inviato che soddisfa i criteri di controllo qualità
22 luglio 2026
Primo Inserito (Effettivo)
27 luglio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
27 luglio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
22 luglio 2026
Ultimo verificato
1 luglio 2026
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Ghidaa-PHD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .